罗氏效仿同行,向美国制造与研发基地投入500亿美元——FirstWord Pharma
Roche follows peers with $50B investment in US manufacturing, research sites - FirstWord Pharma
生物技术与制药领域的最新动态
Roche follows peers with $50B investment in US manufacturing, research sites - FirstWord Pharma
Cytiva expands portfolio with new MabSelect Resins made from renewable agarose for scalable, cost-efficient mAb manufacturing - Express Pharma
Inside Lonza CHI’s Innovation Strategy: Future-Ready Capsules for Complex Drugs - PharmTech.com
Unlocking the Potential of PROTACs in Drug Discovery - Technology Networks
Illumina and Tempus partner to drive the future of precision medicine through genomic AI innovation - PR Newswire
Ethris and Lonza focus on mRNA respiratory condition vaccines - Pharmaceutical Technology
Ethris and Lonza Collaborate to Develop Spray-Dried mRNA Vaccines for Respiratory Disease Prevention - BioSpace
Ethris and Lonza Collaborate to Develop Spray-Dried mRNA Vaccines - Contract Pharma
Ethris and Lonza Collaborate to Develop Spray-Dried mRNA Vaccines for Respiratory Disease Prevention - GEN - Genetic Engineering and Biotechnology News
Catching up with Lonza Capsules and Health Ingredients - Nutritional Outlook
Lonza Investing in Large-Scale Biomanufacturing, Bioconjugation, Drug-Product Manufacturing - DCAT Value Chain Insights
Cytiva expands MabSelect resin portfolio with new solutions for cost-effective and scalable mAb purification - BioSpectrum Asia
SBTi validates Roche’s net-zero targets - Roche
Lonza Implements Streamlined Operating Model - Contract Pharma
Waters Expands Alliance iS Bio HPLC Product Line with Photodiode Array Detector to Enhance Spectral Insights for Biopharma Development & QC - PR Newswire
Illumina Connected Multiomics - Illumina
Lonza Leadership Visits UNH's Tissue Culture Lab - University of New Hampshire
Cytiva broadens Xcellerex X-platform to include 500 L and 2000 L bioreactors - SelectScience
Cytiva Expands Bioreactor Portfolio with Addition of 500-L and 2000-L Bioreactors, Which Will be Exhibited at INTERPHEX 2025 - BioPharm International
Illumina board adds activist investor, elevates Scott Gottlieb to chair - Fierce Biotech